View Older Stories View More Recent Stories

Jan 21, 2025 08:05AM Humacyte (HUMA) Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Jan 16, 2025 05:42PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 16, 2025 04:41PM HUMA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HU

Jan 15, 2025 04:37PM HUMA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important January 17 Deadline in Securities Class Action - H

Jan 13, 2025 09:12PM HUMA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 13, 2025 06:53PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 12, 2025 09:11PM HUMA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 12, 2025 08:52AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 11, 2025 03:52PM HUMA DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 10, 2025 03:52PM HUMA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 9, 2025 02:10PM HUMA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 7, 2025 04:30PM HUMA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 6, 2025 05:51PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 6, 2025 04:24PM ROSEN, A RANKED AND LEADING FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 5, 2025 12:12PM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 4, 2025 09:13PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Jan 1, 2025 05:33PM ROSEN, A LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Dec 31, 2024 12:06PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

Dec 28, 2024 07:30PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 28, 2024 09:19AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 27, 2024 04:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 25, 2024 11:32PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 25, 2024 08:01AM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 23, 2024 10:16AM Humacyte (HUMA) PT Raised to $17 at Benchmark Following FDA approval for SYMVESS

Dec 23, 2024 09:24AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 22, 2024 07:21PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 21, 2024 07:20PM ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 20, 2024 06:43AM Humacyte (HUMA) PT Raised to $15 at H.C. Wainwright

Dec 20, 2024 06:26AM BTIG Reiterates Buy Rating on Humacyte (HUMA)

Dec 19, 2024 10:48PM Humacyte (HUMA) Announces FDA Approval of SYMVESS

Dec 18, 2024 06:50PM Humacyte's (HUMA) Insiders Sell Millions in Stock Amidst Lawsuit and Regulatory Troubles - Hagens Berman

Dec 17, 2024 05:50PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 16, 2024 09:07PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 16, 2024 05:49PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 15, 2024 09:02PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 15, 2024 08:28AM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Dec 14, 2024 09:02PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 13, 2024 09:01PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 13, 2024 08:00PM HUMA INVESTOR ALERT: Kirby McInerney LLP Notifies Humacyte, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Dec 12, 2024 09:01PM ROSEN, A LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 11, 2024 09:00PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

Dec 11, 2024 05:20PM Humacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations - Hagens Berman

Nov 21, 2024 08:03AM Humacyte (HUMA) Clinical Results Highlighting Benefit of the ATEV in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery

Nov 14, 2024 08:06AM Humacyte (HUMA) Announces Pricing of $15.0 Million Registered Direct Offering

Nov 8, 2024 08:02AM Humacyte, Inc. (HUMA) Misses Q3 EPS by 8c

Nov 5, 2024 06:43AM Humacyte (HUMA) PT Raised to $12 at H.C. Wainwright

Oct 28, 2024 07:01AM Humacyte (HUMA) Announces Presentation of Positive Results from V007 Phase 3 AV Access Trial

Oct 18, 2024 08:20AM TD Cowen Reiterates Buy Rating on Humacyte (HUMA)

Oct 18, 2024 07:51AM Piper Sandler Reiterates Neutral Rating on Humacyte (HUMA)

Oct 18, 2024 05:41AM BTIG Reiterates Buy Rating on Humacyte (HUMA)

View More Recent Stories View Older Stories